These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 37906202)

  • 21. Inequity in access to continuous glucose monitoring and health outcomes in paediatric diabetes, a case for national continuous glucose monitoring funding: A cross-sectional population study of children with type 1 diabetes in New Zealand.
    Burnside MJ; Williman JA; Davies HM; Jefferies CA; Paul RG; Wheeler BJ; Wiltshire EJ; Anderson YC; de Bock MI
    Lancet Reg Health West Pac; 2023 Feb; 31():100644. PubMed ID: 36419466
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Racial/Ethnic Inequities in Use of Diabetes Technologies Among Medicare Advantage Beneficiaries With Type 1 Diabetes.
    Kommareddi M; Wherry K; Vigersky RA
    J Clin Endocrinol Metab; 2023 Jun; 108(7):e388-e395. PubMed ID: 36715293
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of Hemoglobin A1c before and after initiation of continuous glucose monitoring in children with type 1 diabetes mellitus.
    Gurnurkar S; Owens L; Chalise S; Vyas N
    J Pediatr Endocrinol Metab; 2021 Mar; 34(3):311-317. PubMed ID: 33618445
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pediatric Medicaid Patients With Type 1 Diabetes Benefit From Continuous Glucose Monitor Technology.
    Ravi SJ; Coakley A; Vigers T; Pyle L; Forlenza GP; Alonso T
    J Diabetes Sci Technol; 2021 May; 15(3):630-635. PubMed ID: 32172603
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship of primary care clinician characteristics with continuous glucose monitoring use and confidence.
    Hall T; Dickinson LM; Callen E; Nease D; Carroll J; Oser T; Warman M; Michaels L; Oser S
    Ann Fam Med; 2022 Apr; 20(20 Suppl 1):. PubMed ID: 36701160
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Racial and Ethnic Disparities in Rates of Continuous Glucose Monitor Initiation and Continued Use in Children With Type 1 Diabetes.
    Lai CW; Lipman TH; Willi SM; Hawkes CP
    Diabetes Care; 2021 Jan; 44(1):255-257. PubMed ID: 33177169
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Partnering for Better Health: Using Continuous Glucose Monitoring and Clinical Pharmacist Collaboration to Improve Glycemic Control in Underserved Patients With Type 2 Diabetes.
    Powell J; Mulani SR
    Clin Ther; 2024 Jan; 46(1):e7-e11. PubMed ID: 38165024
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of Continuous Glucose Monitoring on Glycemic Control in Adolescents and Young Adults With Type 1 Diabetes: A Randomized Clinical Trial.
    Laffel LM; Kanapka LG; Beck RW; Bergamo K; Clements MA; Criego A; DeSalvo DJ; Goland R; Hood K; Liljenquist D; Messer LH; Monzavi R; Mouse TJ; Prahalad P; Sherr J; Simmons JH; Wadwa RP; Weinstock RS; Willi SM; Miller KM; ;
    JAMA; 2020 Jun; 323(23):2388-2396. PubMed ID: 32543683
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Integrated sensor-augmented pump therapy systems [the MiniMed® Paradigm™ Veo system and the Vibe™ and G4® PLATINUM CGM (continuous glucose monitoring) system] for managing blood glucose levels in type 1 diabetes: a systematic review and economic evaluation.
    Riemsma R; Corro Ramos I; Birnie R; Büyükkaramikli N; Armstrong N; Ryder S; Duffy S; Worthy G; Al M; Severens J; Kleijnen J
    Health Technol Assess; 2016 Feb; 20(17):v-xxxi, 1-251. PubMed ID: 26933827
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does introduction of continuous glucose monitoring at diagnosis of type 1 diabetes increase uptake in children and adolescents?
    Hobbs A; Thus M; Couper J; Tham E; Fairchild J
    Pediatr Diabetes; 2022 Feb; 23(1):98-103. PubMed ID: 34820964
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diabetes Specialists Value Continuous Glucose Monitoring Despite Challenges in Prescribing and Data Review Process.
    Kompala T; Wong J; Neinstein A
    J Diabetes Sci Technol; 2023 Sep; 17(5):1265-1273. PubMed ID: 35403469
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Salient characteristics of youth with type 1 diabetes initiating continuous glucose monitoring.
    Telo GH; Volkening LK; Butler DA; Laffel LM
    Diabetes Technol Ther; 2015 Jun; 17(6):373-8. PubMed ID: 25749206
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of Continuous Glucose Monitoring on Hypoglycemia in Older Adults With Type 1 Diabetes: A Randomized Clinical Trial.
    Pratley RE; Kanapka LG; Rickels MR; Ahmann A; Aleppo G; Beck R; Bhargava A; Bode BW; Carlson A; Chaytor NS; Fox DS; Goland R; Hirsch IB; Kruger D; Kudva YC; Levy C; McGill JB; Peters A; Philipson L; Philis-Tsimikas A; Pop-Busui R; Shah VN; Thompson M; Vendrame F; Verdejo A; Weinstock RS; Young L; Miller KM;
    JAMA; 2020 Jun; 323(23):2397-2406. PubMed ID: 32543682
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Racial disparities in treatment and outcomes of children with type 1 diabetes.
    Lipman TH; Smith JA; Patil O; Willi SM; Hawkes CP
    Pediatr Diabetes; 2021 Mar; 22(2):241-248. PubMed ID: 33871154
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Continuous glucose monitors and virtual care in high-risk, racial and ethnic minority populations: Toward promoting health equity.
    Vrany EA; Hill-Briggs F; Ephraim PL; Myers AK; Garnica P; Fitzpatrick SL
    Front Endocrinol (Lausanne); 2023; 14():1083145. PubMed ID: 36761197
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of CGM Access Expansion on Uptake Among Patients on Medicaid With Diabetes.
    Ni K; Tampe CA; Sol K; Richardson DB; Pereira RI
    Diabetes Care; 2023 Feb; 46(2):391-398. PubMed ID: 36480729
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting Technology in Underserved Adults With Type 1 Diabetes: Effect of Diabetes Practice Transformations on Improving Equity in CGM Prescribing Behaviors.
    Mathias P; Mahali LP; Agarwal S
    Diabetes Care; 2022 Oct; 45(10):2231-2237. PubMed ID: 36054022
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diabetes Device Use and Glycemic Control among Youth with Type 1 Diabetes: A Single-Center, Cross-Sectional Study.
    Sheikh K; Bartz SK; Lyons SK; DeSalvo DJ
    J Diabetes Res; 2018; 2018():5162162. PubMed ID: 30151393
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Perceived Burdens and Benefits Associated With Continuous Glucose Monitor Use in Type 1 Diabetes Across the Lifespan.
    Divan V; Greenfield M; Morley CP; Weinstock RS
    J Diabetes Sci Technol; 2022 Jan; 16(1):88-96. PubMed ID: 33356514
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stepwise approach to continuous glucose monitoring interpretation for internists and family physicians.
    Szmuilowicz ED; Aleppo G
    Postgrad Med; 2022 Nov; 134(8):743-751. PubMed ID: 35930313
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.